South Africa to Launch Groundbreaking HIV Prevention Injection on June 5

Benue, with Nigeria’s heaviest HIV treatment burden, launches long-acting prevention drug

The Benue State Government has launched Lenacapavir, a long-acting injectable drug for HIV prevention, as part of efforts to curb new infections and end AIDS by 2030. The post Benue, with Nigeria’s heaviest HIV treatment burden, launches long-acting prevention drug appeared first on Premium Times Nigeria.

Benue unveils twice-yearly drug lenacapavir for HIV prevention

Benue State launches Lenacapavir, a new twice-yearly injectable drug for HIV prevention, offering a discreet and effective option to fight high prevalence. Read More: https://punchng.com/benue-unveils-twice-yearly-drug-lenacapavir-for-hiv-prevention/

South Africa: Groundbreaking HIV Drug, Lenacapavir, to Be Launched Next Month

[SAnews.gov.za] The launch of Lenacapavir - a groundbreaking HIV drug - will be held on June 5 in Mpumalanga.

Game-changing HIV injection set for rollout in June

The department has identified specific demographics for the initial phase of the rollout to ensure the most vulnerable populations receive immediate access.

South Africa to launch groundbreaking HIV prevention injection on June 5

On June 5, South Africa will unveil lenacapavir, a revolutionary long-acting HIV prevention injection, poised to transform public health and dramatically reduce new infections.

South Africa sets launch date for HIV prevention drug Lenacapavir rollout

While delivering the Department of Health's budget vote, the Minister of Health, Dr Aaron Motsoaledi, announced that South Africa will officially launch the groundbreaking HIV drug, Lenacapavir, in Mpumalanga on 5 June 2026.